Works matching IS 03407004 AND DT 2009 AND VI 58 AND IP 1

Results: 15

Vaccine-specific local T cell reactivity in immunotherapy-associated vitiligo in melanoma patients.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 1, p. 145, doi. 10.1007/s00262-008-0506-5

By:

Jacobs, Joannes;
Aarntzen, Erik;
Sibelt, Lenny;
Blokx, Willeke;
Boullart, Anna;
Gerritsen, Marie-Jeanne;
Hoogerbrugge, Peter;
Figdor, Carl;
Adema, Gosse;
Punt, Cornelis;
Vries, I.

Publication type:

Article

IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 1, p. 153, doi. 10.1007/s00262-008-0513-6

By:

Löb, Stefan;
Königsrainer, Alfred;
Zieker, Derek;
Brücher, Björn;
Rammensee, Hans-Georg;
Opelz, Gerhard;
Terness, Peter

Publication type:

Article

Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 1, p. 15, doi. 10.1007/s00262-008-0516-3

By:

Cho, HanByoul;
Hur, Hye;
Kim, Sang;
Kim, Sung;
Kim, Jae;
Kim, Young;
Lee, Kook

Publication type:

Article

Effect of BCG stimulus on proinflammatory cytokine production in laryngeal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 1, p. 25, doi. 10.1007/s00262-008-0520-7

By:

Conti-Freitas, Luiz;
Foss-Freitas, Maria;
Mamede, Rui;
Foss, Norma

Publication type:

Article

In vivo effects of zoledronic acid on peripheral γδ T lymphocytes in early breast cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 1, p. 31, doi. 10.1007/s00262-008-0521-6

By:

Santini, Daniele;
Martini, Federico;
Fratto, Maria;
Galluzzo, Sara;
Vincenzi, Bruno;
Agrati, Chiara;
Turchi, Federica;
Piacentini, Paola;
Rocci, Laura;
Manavalan, John;
Tonini, Giuseppe;
Poccia, Fabrizio

Publication type:

Article

Increased migration of Langerhans cells in response to HPV16 E6 and E7 oncogene silencing: role of CCL20.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 1, p. 39, doi. 10.1007/s00262-008-0522-5

By:

Caberg, Jean-Hubert;
Hubert, Pascale;
Herman, Ludivine;
Herfs, Michael;
Roncarati, Patrick;
Boniver, Jacques;
Delvenne, Philippe

Publication type:

Article

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 1, p. 49, doi. 10.1007/s00262-008-0523-4

By:

Diaz-Montero, C.;
Salem, Mohamed;
Nishimura, Michael;
Garrett-Mayer, Elizabeth;
Cole, David;
Montero, Alberto

Publication type:

Article

Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 1, p. 61, doi. 10.1007/s00262-008-0526-1

By:

Schulze, T.;
Kemmner, W.;
Weitz, J.;
Wernecke, K.-D.;
Schirrmacher, V.;
Schlag, P.

Publication type:

Article

Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 1, p. 71, doi. 10.1007/s00262-008-0527-0

By:

Preise, Dina;
Oren, Roni;
Glinert, Itai;
Kalchenko, Vyacheslav;
Jung, Steffen;
Scherz, Avigdor;
Salomon, Yoram

Publication type:

Article

Expression and function of T cell homing molecules in Hodgkin’s lymphoma.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 1, p. 85, doi. 10.1007/s00262-008-0528-z

By:

Machado, Lee;
Jarrett, Ruth;
Morgan, Susan;
Murray, Paul;
Hunter, Beatrix;
Hamilton, Emma;
Crocker, John;
Thomas, Wendy;
Steven, Neil;
Ismail, Tariq;
Chapman, Ann;
Adams, David;
Lee, Steven

Publication type:

Article

Therapeutic window of an EpCAM/CD3-specific BiTE antibody in mice is determined by a subpopulation of EpCAM-expressing lymphocytes that is absent in humans.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 1, p. 95, doi. 10.1007/s00262-008-0529-y

By:

Amann, Maria;
Friedrich, Matthias;
Lutterbuese, Petra;
Vieser, Eva;
Lorenczewski, Grit;
Petersen, Laetitia;
Brischwein, Klaus;
Kufer, Peter;
Kischel, Roman;
Baeuerle, Patrick;
Schlereth, Bernd

Publication type:

Article

Systemic immune effects of adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide and/or radiotherapy in breast cancer: a longitudinal study.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 1, p. 111, doi. 10.1007/s00262-008-0530-5

By:

Mozaffari, Fariba;
Lindemalm, Christina;
Choudhury, Aniruddha;
Granstam-Björneklett, Helena;
Lekander, Mats;
Nilsson, Bo;
Ojutkangas, Marja-Leena;
Österborg, Anders;
Bergkvist, Leif;
Mellstedt, Håkan

Publication type:

Article

Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 1, p. 121, doi. 10.1007/s00262-008-0533-2

By:

Vujanovic, Lazar;
Whiteside, Theresa;
Potter, Douglas;
Chu, Jessica;
Ferrone, Soldano;
Butterfield, Lisa

Publication type:

Article

MSI-H colorectal cancers preferentially retain and expand intraepithelial lymphocytes rather than peripherally derived CD8<sup>+</sup> T cells.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 1, p. 135, doi. 10.1007/s00262-008-0534-1

By:

Baker, Kristi;
Foulkes, William;
Jass, Jeremy

Publication type:

Article

Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 1, p. 1, doi. 10.1007/s00262-008-0568-4

By:

Engell-Noerregaard, Lotte;
Hansen, Troels;
Andersen, Mads;
thor Straten, Per;
Svane, Inge

Publication type:

Article